Author
Listed:
- Shintaro Okumura
(Research Institute for Microbial Diseases (RIMD), Osaka University
The Cancer Institute, Japanese Foundation for Cancer Research (JFCR)
Graduate School of Medicine, Kyoto University)
- Yusuke Konishi
(Research Institute for Microbial Diseases (RIMD), Osaka University)
- Megumi Narukawa
(Research Institute for Microbial Diseases (RIMD), Osaka University)
- Yuki Sugiura
(Keio University School of Medicine)
- Shin Yoshimoto
(The Cancer Institute, Japanese Foundation for Cancer Research (JFCR)
LSI Medience Corporation)
- Yuriko Arai
(The Cancer Institute, Japanese Foundation for Cancer Research (JFCR))
- Shintaro Sato
(Research Institute for Microbial Diseases (RIMD), Osaka University)
- Yasuo Yoshida
(School of Dentistry, Aichi Gakuin University)
- Shunya Tsuji
(Research Institute for Microbial Diseases (RIMD), Osaka University)
- Ken Uemura
(Research Institute for Microbial Diseases (RIMD), Osaka University)
- Masahiro Wakita
(Immunology Frontier Research Centre (IFReC), Osaka University)
- Tatsuyuki Matsudaira
(Research Institute for Microbial Diseases (RIMD), Osaka University)
- Tomonori Matsumoto
(Research Institute for Microbial Diseases (RIMD), Osaka University)
- Shimpei Kawamoto
(Research Institute for Microbial Diseases (RIMD), Osaka University)
- Akiko Takahashi
(The Cancer Institute, Japanese Foundation for Cancer Research (JFCR))
- Yoshiro Itatani
(Graduate School of Medicine, Kyoto University)
- Hiroaki Miki
(Research Institute for Microbial Diseases (RIMD), Osaka University)
- Manabu Takamatsu
(The Cancer Institute Hospital, JFCR)
- Kazutaka Obama
(Graduate School of Medicine, Kyoto University)
- Kengo Takeuchi
(The Cancer Institute, Japanese Foundation for Cancer Research (JFCR)
The Cancer Institute Hospital, JFCR)
- Makoto Suematsu
(Keio University School of Medicine)
- Naoko Ohtani
(Osaka City University Graduate School of Medicine)
- Yosuke Fukunaga
(The Cancer Institute Hospital, JFCR)
- Masashi Ueno
(The Cancer Institute Hospital, JFCR)
- Yoshiharu Sakai
(Graduate School of Medicine, Kyoto University)
- Satoshi Nagayama
(The Cancer Institute Hospital, JFCR)
- Eiji Hara
(Research Institute for Microbial Diseases (RIMD), Osaka University
The Cancer Institute, Japanese Foundation for Cancer Research (JFCR)
Immunology Frontier Research Centre (IFReC), Osaka University)
Abstract
Emerging evidence is revealing that alterations in gut microbiota are associated with colorectal cancer (CRC). However, very little is currently known about whether and how gut microbiota alterations are causally associated with CRC development. Here we show that 12 faecal bacterial taxa are enriched in CRC patients in two independent cohort studies. Among them, 2 Porphyromonas species are capable of inducing cellular senescence, an oncogenic stress response, through the secretion of the bacterial metabolite, butyrate. Notably, the invasion of these bacteria is observed in the CRC tissues, coinciding with the elevation of butyrate levels and signs of senescence-associated inflammatory phenotypes. Moreover, although the administration of these bacteria into ApcΔ14/+ mice accelerate the onset of colorectal tumours, this is not the case when bacterial butyrate-synthesis genes are disrupted. These results suggest a causal relationship between Porphyromonas species overgrowth and colorectal tumourigenesis which may be due to butyrate-induced senescence.
Suggested Citation
Shintaro Okumura & Yusuke Konishi & Megumi Narukawa & Yuki Sugiura & Shin Yoshimoto & Yuriko Arai & Shintaro Sato & Yasuo Yoshida & Shunya Tsuji & Ken Uemura & Masahiro Wakita & Tatsuyuki Matsudaira &, 2021.
"Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion,"
Nature Communications, Nature, vol. 12(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25965-x
DOI: 10.1038/s41467-021-25965-x
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-25965-x. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.